(WSPA)—Inflammatory bowel disease (IBD) targets your digestive system. As part of our “Ask the Expert” series, in partnership with Bon Secours St. Francis, 7NEWS spoke with an IBD director to learn ...

Under the terms of the agreement Boehringer receives global rights to the asset, excluding greater China. Simcere is eligible to receive an upfront payment as well as success-based development, ...

Ease the symptoms of a UC flare, such as diarrhea, abdominal pain, and fever using expert-backed tips, and learn when to seek immediate medical attention.

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The treatment landscape for inflammatory ...

Microbiota therapeutics, such as fecal microbiota transplantation (FMT), could offer more diverse, personalized treatment options for patients with inflammatory bowel disease (IBD), particularly for ...

Boehringer Ingelheim announced a license and collaboration agreement with Simcere Pharmaceuticals to develop Simcere’s ...

Boehringer Ingelheim and Simcere are developing SIM0709, a pre-clinical bispecific antibody, for treating inflammatory bowel disease (IBD).

Inflammatory bowel disease (IBD) can cause various symptoms in females not typically seen in males. These may include painful menstruation, fertility issues, anemia, and pain during sex. IBD describes ...